Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Arecor Therapeutics plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2027 | $1.05M | $1.04M - $1.06M | -$1.05M | -$0.113 | 1 |
| Dec 2026 | $900.0K | $878.0K - $922.0K | -$900.0K | -$0.155 | 2 |
| Dec 2025 | $3.10M | $3.07M - $3.13M | -$3.10M | -$0.013 | 2 |
| Dec 2024 | $5.10M | $4.91M - $5.31M | -$5.10M | -$0.273 | 3 |
| Dec 2023 | $4.90M | $4.84M - $4.95M | -$4.90M | -$0.283 | 2 |
| Dec 2022 | $2.40M | $2.12M - $2.68M | -$2.40M | -$0.325 | 1 |
| Dec 2021 | $1.16M | $1.03M - $1.29M | -$1.16M | -$0.26 | 1 |